Translational Research in Headache: From Bench to Bedside and Back Again

Authors

  • Alicia Gonzalez-Martinez Neurology Department, La Princesa University Hospital, Madrid, Spain; Translational Research Group in Multimodal Biomarkers in Neurological Diseases, IIS-Princesa, Madrid, Spain; Autonomous University of Madrid (UAM), Madrid, Spain https://orcid.org/0000-0002-1228-1503

DOI:

https://doi.org/10.46531/sinapse/ED/243/2026

Keywords:

Biomedical Research, Headache, Migraine Disorders, Precision Medicine, Translational Research, Biomedical

Downloads

Download data is not yet available.

References

GBD 2023 Headache Collaborators. Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol. 2025;24:1005-15. doi: 10.1016/S1474-4422(25)00402-8.

Puledda F, Silva EM, Suwanalong K, Goadsby PJ. Migraine: from pathophysiology to treatment. J Neurol. 2023;270:3654-66. doi: 10.1007/s00415-023-11706-1.

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97:553-622. doi: 10.1152/physrev.00034.2015.

Krivoshein G, Watt MV, Jordà-Baleri T, Pold K, Gkotzamanis V, van den Maagdenberg AM, et al. From bench to bedside: relevant animal models across the migraine attack phases. J Headache Pain. 2026;27:147. doi: 10.1186/s10194-026-02369-0.

Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365-91. doi: 10.1146/annurev-physiol-030212-183717.

Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol. 2009;8:679-90. doi: 10.1016/S1474-4422(09)70090-0.

Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35:6619-29. doi: 10.1523/JNEUROSCI.0373-15.2015.

Olesen J. Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review. J Headache Pain. 2024;25:105. doi: 10.1186/s10194-024-01796-1.

Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183-7. doi: 10.1002/ana.410280213.

Pietra AD, Kuburas A, Russo AF. PACAP versus CGRP in migraine: From mouse models to clinical translation. Cephalalgia. 2025;45:3331024251364242. doi: 10.1177/03331024251364242.

Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A. Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet. 2025;405:1014-26. doi: 10.1016/S0140-6736(25)00109-6. Erratum in: Lancet. 2025;406:134. doi: 10.1016/S0140-6736(25)01396-0.

Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24:91-100. doi: 10.1080/14728222.2020.1724285.

Rubio-Beltran E, Labastida-Ramirez A, Haanes KA. PACAP in migraine pathophysiology. Cephalalgia. 2018;38:1092-1108.

Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009;132:16-25. doi: 10.1093/brain/awn307.

Ashina H, Christensen RH, Hay DL, Pradhan AA, Hoffmann J, Reglodi D, et al. Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine. Nat Rev Neurol. 2024;20:660-70. doi: 10.1038/s41582-024-01011-4.

Karlsson WK, Ashina H, Cullum CK, Christensen RH, Al-Khazali HM, Amin FM, et al. REFORM Investigators. The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics. J Headache Pain. 2023;24:70. doi: 10.1186/s10194-023-01604-2.

Sánchez-Rodríguez C, Gago-Veiga AB, García-Azorín D, Guerrero-Peral AL, Gonzalez-Martinez A, et al. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data. Curr Pain Headache Rep. 2023.

García-Castillo MC, Sierra-Mencia Á, Caronna E, Toledo-Alfocea D, Jaimes A, Urtiaga S, et al. Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study. Headache. 2026;66:1330-41. doi: 10.1111/head.70086.

Gómez Martín de la Escalera L, Trillo S, Barbosa Del Olmo A, Benavides Bernaldo de Queirós C, Valiente E, Gago-Veiga AB, et al. Neuroimaging biomarkers in migraine with aura mimicking stroke: A qualitative and quantitative analysis of perfusion CT alterations. Headache. 2026 (in press). doi: 10.1111/head.70126.

Petrušić I, Messina R, Pellesi L, Azorin DG, Chiang CC, Pietra AD, et al. Application of machine learning in migraine classification: a call for study design standardization and global collaboration. J Headache Pain. 2025;26:200. doi: 10.1186/s10194-025-02134-9.

Downloads

Published

2026-06-29

How to Cite

1.
Gonzalez-Martinez A. Translational Research in Headache: From Bench to Bedside and Back Again. Sinapse [Internet]. 2026 Jun. 29 [cited 2026 Jun. 30];26(2):101-4. Available from: https://sinapse.pt/index.php/journal/article/view/243

Issue

Section

Editorial